Aqr Capital Management LLC Ngm Biopharmaceuticals Inc Transaction History

Aqr Capital Management LLC

  • $64.6 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.17 - $1.92 $19,846 - $32,568
16,963 New
16,963 $26,000
Q4 2022

Feb 14, 2023
BUY
$3.41 - $12.93 $260,786 - $988,847
76,477 New
76,477 $383,000
Q1 2022

May 16, 2022
SELL
$13.81 - $18.6 $151,564 - $204,135
-10,975 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$17.26 - $22.02 $153,009 - $195,207
-8,865 Reduced 44.68%
10,975 $194,000
Q3 2021

Nov 15, 2021
BUY
$20.15 - $26.19 $399,776 - $519,609
19,840 New
19,840 $417,000

Others Institutions Holding NGM

# of Institutions
5
Shares Held
2.6M
Call Options Held
300
Put Options Held
0
View Full List

About NGM BIOPHARMACEUTICALS INC

NGM Quotes by TradingView
  • Ticker NGM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 80,365,904
  • Description
  • NGM Biopharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of novel therapeutics to treat liver and metabolic diseases, retinal diseases, and cancer. The company's product candidates include Aldafermin, an engineered analog of human hormone fibroblast growth factor 19, which is in Phase IIb clinical trial...
More about NGM
Track This Portfolio

Track Aqr Capital Management LLC Portfolio

Follow Aqr Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Aqr Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Aqr Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email